Skip to content

''Diagnostic value of optical spectral transmission in patients with inflammatory rheumatic diseases''

''Diagnostic value of optical spectral transmission in patients with inflammatory rheumatic diseases'' - OST

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00016752
Enrollment
500
Registered
2019-02-21
Start date
2018-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M06 M07 M10

Interventions

Group 1: OST and ultrasound values comparison between a RA group of patients and a control group. Moreover, examination of the OST correlations with clinical, laboratory and arthrosonohgraphic activit

Sponsors

ACURA Rheumatology Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inflammatory Joint disease

Exclusion criteria

Exclusion criteria: Deformities of the hands, joint implants, Pregnancy, photosensitivity

Design outcomes

Primary

MeasureTime frame
Is OST able to differentiate between inflamed and non inflamed joints?

Secondary

MeasureTime frame
Does OST associate with clinical, laboratory and arthrosonographic Parameters of disease activity?

Countries

Germany

Contacts

Public ContactKonstantinos Triantafyllias

ACURA Rheumatology Center Rhineland Palatinate

Konstantinos.Triantafyllias@kh-acura-kliniken.com0671-932251

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026